Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis.
Padmapriyadarsini C, Vohra V, Bhatnagar A, Solanki R, Sridhar R, Anande L, Muthuvijaylakshmi M, Bhatia M, Jeyadeepa B, Taneja G, Balaji S, Shah P, Saravanan N, Chauhan V, Kumar H, Ponnuraja C, Livchits V, Bahl M, Alavadi U, Sachdeva KS, Swaminathan S; for BEAT India Team. Padmapriyadarsini C, et al. Among authors: sachdeva ks. Clin Infect Dis. 2022 Jun 29;76(3):e938-46. doi: 10.1093/cid/ciac528. Online ahead of print. Clin Infect Dis. 2022. PMID: 35767251 Free PMC article.
A multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimens.
Raizada N, Sachdeva KS, Chauhan DS, Malhotra B, Reddy K, Dave PV, Mundade Y, Patel P, Ramachandran R, Das R, Solanki R, Wares DF, Sahu S, O'Brien R, Paramasivan CN, Dewan PK. Raizada N, et al. Among authors: sachdeva ks. PLoS One. 2014 Feb 19;9(2):e88626. doi: 10.1371/journal.pone.0088626. eCollection 2014. PLoS One. 2014. PMID: 24586360 Free PMC article.
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.
Raizada N, Sachdeva KS, Sreenivas A, Vadera B, Gupta RS, Parmar M, Kulsange S, Babre A, Thakur R, Gray C, Ramachandran R, Alavadi U, Ghedia M, Vollepore B, Dewan P, Boehme C, Paramsivan CN. Raizada N, et al. Among authors: sachdeva ks. PLoS One. 2014 Feb 26;9(2):e89301. doi: 10.1371/journal.pone.0089301. eCollection 2014. PLoS One. 2014. PMID: 24586675 Free PMC article.
Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
Raizada N, Sachdeva KS, Nair SA, Kulsange S, Gupta RS, Thakur R, Parmar M, Gray C, Ramachandran R, Vadera B, Ekka S, Dhawan S, Babre A, Ghedia M, Alavadi U, Dewan P, Khetrapal M, Khanna A, Boehme C, Paramsivan CN. Raizada N, et al. Among authors: sachdeva ks. PLoS One. 2014 Aug 20;9(8):e105346. doi: 10.1371/journal.pone.0105346. eCollection 2014. PLoS One. 2014. PMID: 25140877 Free PMC article.
Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
Sachdeva KS, Raizada N, Sreenivas A, Van't Hoog AH, van den Hof S, Dewan PK, Thakur R, Gupta RS, Kulsange S, Vadera B, Babre A, Gray C, Parmar M, Ghedia M, Ramachandran R, Alavadi U, Arinaminpathy N, Denkinger C, Boehme C, Paramasivan CN. Sachdeva KS, et al. PLoS One. 2015 May 21;10(5):e0126065. doi: 10.1371/journal.pone.0126065. eCollection 2015. PLoS One. 2015. PMID: 25996389 Free PMC article.
Treatment of childhood tuberculosis in India.
Swaminathan S, Sachdeva KS. Swaminathan S, et al. Among authors: sachdeva ks. Int J Tuberc Lung Dis. 2015 Dec;19 Suppl 1:43-46. doi: 10.5588/ijtld.15.0611. Int J Tuberc Lung Dis. 2015. PMID: 26564540
Insights in tuberculosis immunology: Role of NKT and T regulatory cells.
Pandey P, Bhatnagar AK, Mohan A, Sachdeva KS, Vajpayee M, Das BK, Samantaray JC, Guleria R, Singh UB. Pandey P, et al. Among authors: sachdeva ks. Int J Mycobacteriol. 2019 Oct-Dec;8(4):333-340. doi: 10.4103/ijmy.ijmy_141_19. Int J Mycobacteriol. 2019. PMID: 31793502
Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysis.
Salhotra VS, Sachdeva KS, Kshirsagar N, Parmar M, Ramachandran R, Padmapriyadarsini C, Patel Y, Mehandru L, Jaju J, Ponnuraja C, Gupta M, Kalaiselvan V, Shamim A, Khaparde S, Swaminathan S; Bedaquiline CAP Site Teams. Salhotra VS, et al. Among authors: sachdeva ks. Indian J Tuberc. 2020 Jan;67(1):29-37. doi: 10.1016/j.ijtb.2019.10.002. Epub 2019 Oct 16. Indian J Tuberc. 2020. PMID: 32192613
95 results